Presentation is loading. Please wait.

Presentation is loading. Please wait.

Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization.

Similar presentations


Presentation on theme: "Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization."— Presentation transcript:

1 Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial  Stefano Palomba, M.D., Angela Falbo, M.D., Laura Carrillo, M.D., Maria Teresa Villani, M.D., Francesco Orio, M.D., Tiziana Russo, M.D., Annalisa Di Cello, M.D., Fulvio Cappiello, M.D., Sabina Capasso, M.D., Achille Tolino, M.D., Annamaria Colao, M.D., Pasquale Mastrantonio, M.D., Giovanni Battista La Sala, M.D., Fulvio Zullo, M.D., Ettore Cittadini, M.D.  Fertility and Sterility  Volume 96, Issue 6, Pages e4 (December 2011) DOI: /j.fertnstert Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions

2 Supplemental Figure 1 Flow diagram of the clinical trial according to the CONSORT guidelines. Fertility and Sterility  , e4DOI: ( /j.fertnstert ) Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions


Download ppt "Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization."

Similar presentations


Ads by Google